Considering the significant role of B cells (and myeloid cells) in the development of SSc, we examined the effect of BTK inhibition on both skin and lung fibrosis in a BLM-induced mouse model of this disease, as well as in two additional mouse models of end organ inflammation, as described below. Here, BTK is linked to pulmonary fibrosis.